<DOC>
	<DOCNO>NCT01532349</DOCNO>
	<brief_summary>This research do study effectiveness vitamin D ( cholecalciferol ) modify hepcidin level child chronic kidney disease ( CKD ) . Anemia common problem child CKD . Anemia body enough healthy red blood cell . Hepcidin protein blood interferes body 's production red blood cell . This study see vitamin D lower hepcidin level child young adult CKD . If , could use additional treatment anemia child , addition current therapy already use include iron supplement erythropoietin . People age 1 21 CKD may consider study .</brief_summary>
	<brief_title>Vitamin D Modifier Serum Hepcidin Children With Chronic Kidney Disease</brief_title>
	<detailed_description>Vitamin D Supplementation practical inexpensive intervention safe , readily available clinically indicate . Substantial recent evidence suggest vitamin D may modify inflammatory pathway CKD . There high probability benefit low probability harm easily modifiable factor . 25D level effectively modify oral supplementation cholecalciferol . To best knowledge , study examine effect oral cholecalciferol supplementation hepcidin level conduct child either CKD disease . We conduct randomize open-label control trial oral cholecalciferol supplementation child age 1-21 year stage 2-5 ( pre-dialysis ) CKD receive regular nephrology follow-up tertiary-care child 's hospital ( Johns Hopkins Children 's Center ) . The intervention model parallel assignment . Children randomly allocate receive either cholecalciferol supplementation 4000 IU per day ( 28,000 IU weekly ) accord KDOQI recommend supplementation child mild 25D deficiency , treat 400 IU/day ( 2,800 IU/weekly ) , recommend dietary allowance . ( 1 ) Allocation double-blinded prevent knowledge allocation status affect interpretation result . Study participant prescribe clinically indicate additional cholecalciferol supplementation 3-month laboratory measure obtain , base serum 25D level end study period . ( 1 ) We propose supplementation dose 4000 IU/day child CKD , consider safe dose KDOQI standard ; vitamin D2 dose high 10,000 IU/day give French patient CKD &gt; 1 year evidence vitamin D toxicity . ( 2 ) 25D level 40 80 indicative `` sufficiency '' , safe upper limit intake , risk hypercalcemia negligible , define 10,000 IU/day . ( 3 , 4 ) Cholecalciferol provide tablet ( vitamin D 2000 IU tablet 400 IU tablet , National Vitamin Company , Casa Grande , AZ ) liquid ( Enfamil® D-Vi-Sol™ Drops , 400 IU per mL ) form , base ability tolerate preference subject . Participants monitor sign 25D toxicity ( hypercalcemia , hyperphosphatemia , hypercalciuria ) follow period 1 month 3 month baseline . Data Safety Monitoring Board review serum calcium , phosphorus , urine calcium : creatinine ratio value one month visit ; subject show evidence hypercalcemia hyperphosphatemia ( serum value &gt; upper limit normal , age-specific value , see Table 3 ) , study drug discontinue . ( 3 ) If subject demonstrate evidence hypercalciuria ( urine calcium : cr ratio &gt; 0.6 1-2 year old &gt; 0.2 &gt; 2 year old ) study drug discontinue . ( 5 ) In addition , 25-hydroxy vitamin D level &gt; 80 ng/mL reach , study drug discontinue . In subject study drug discontinue , 3-month laboratory data still collect . In case hypoalbuminemia ( serum albumin &lt; 3.5 g/dL ) correct total serum calcium calculate use formula : Corrected calcium ( mg/dL ) = serum calcium ( mg/dL ) + 0.8 ( 4 - serum albumin [ g/dL ] ) ( 2 ) Standardized blood pressure measurement include three manual BP measurement conduct five minute rest aneroid sphygmomanometer , least 30 second apart . 1 . KDOQI Work Group . KDOQI clinical practice guideline nutrition child CKD : 2008 update . executive summary . Am J Kidney Dis . 2009 Mar ; 53 ( 3 Suppl 2 ) : S11-104 . 2 . KDOQI clinical practice guideline bone metabolism disease child chronic kidney disease . Am J Kidney Dis . 2005 ; 46 ( Supplement 1 ) : S1-S122 . 3 . Querfeld U , Mak RH . Vitamin D deficiency toxicity chronic kidney disease : In search therapeutic window . Pediatr Nephrol . 2010 Jun 22 . 4 . Shroff R , Knott C , Rees L. The virtue vitamin D -- much much ? Pediatr Nephrol . 2010 Sep ; 25 ( 9 ) :1607-20 . 5 . Kruse K , Kracht U , Kruse U . Reference value urinary calcium excretion screen hypercalciuria child adolescent . Eur J Pediatr . 1984 Nov ; 143 ( 1 ) :25-31 .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Hepcidins</mesh_term>
	<criteria>Clinical diagnosis stage 25 Chronic Kidney Disease ( estimate glomerular filtration rate [ GFR ] 15 &lt; 90 ml/min/1.73m2 ) base new bedside Schwartz formula estimation use serum creatinine height [ height cm x 0.413/serum creatinine ] 121 year age Willingness ability provide inform consent assent Children le 1 year age ( risk vitamin D toxicity may increase ) great 21 year time study screen Children document history hypercalcemia nephrolithiasis Children GI tract discontinuity ( ostomy ) Current pregnancy pregnancy within last 12 month Children know anemiarelated disorder include sickle cell anemia , thalassemia Children severe 25D deficiency ( &lt; 5 ng/mL ) likely associate severe morbidity require prompt high dose vitamin D supplementation , 25D level &gt; 60 ng/mL could associate increase risk vitamin D toxicity</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>chronic kidney disease</keyword>
	<keyword>anemia</keyword>
</DOC>